About Hemanext
Hemanext is a private company based in Lexington, Massachusetts. It has reported $134,600,248 raised in ten offerings on Form D since December 2013.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 18, 2025 | Aug 5, 2025 | $19,978,442of $24.0M target | 29 | $688K | EquityRule 506(b) | Form D ↗ |
| Nov 7, 2024 | Jul 31, 2025 | $21,714,277fully sold | 51 | $425K | EquityRule 506(b) | Form D ↗ |
| Dec 18, 2023 | Jan 8, 2024 | $5,005,000of $10.0M target | 10 | $500K | EquityRule 506(b) | Form D ↗ |
| Jun 21, 2023 | Nov 8, 2023 | $11,285,000fully sold | 20 | $564K | Equity, OptionsRule 506(b) | Form D ↗ |
| Jul 19, 2022 | Feb 7, 2023 | $13,248,996of $15.0M target | 38 | $348K | EquityRule 506(b) | Form D ↗ |
| Aug 8, 2019 | Oct 25, 2019amended Oct 15, 2021 | $39,636,597of $59.4M target | 39 | $1.0M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Feb 2, 2018 | Feb 6, 2018amended Oct 26, 2018 | $8,750,000of $16.0M target | 6 | $1.4M | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 24, 2017 | Dec 19, 2017 | $2,700,000of $5.0M target | 6 | $450K | EquityRule 506(b) | Form D ↗ |
| Not yet | Dec 20, 2016 | $0target not set | 0 | — | EquityRule 506(b) | Form D ↗ |
| Jul 22, 2011 | Dec 16, 2013 | $12,281,936of $17.6M target | 3 | $4.0M | Equity, OptionsRule 506(b) | Form D ↗ |
| Total, ten offerings | $134,600,248 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Hemanext's Form D filed Aug 5, 2025.
Earlier filings also listed Richard Perle (director, last listed Jan 2024), Michael Testa (director, last listed Jan 2024), Martin Cannon (executive officer and director, last listed Feb 2023), Kimberly Dorsch (vice president, clinical affairs, last listed Feb 2023), Guy Cogan (director, last listed Feb 2023), Alex Marichal (vice president of marketing, last listed Feb 2023), Joseph Barrett (general counsel and secretary, last listed Oct 2018) and David Herman (director, last listed Oct 2018).